latrepirdine has been researched along with methylene blue in 5 studies
| Studies (latrepirdine) | Trials (latrepirdine) | Recent Studies (post-2010) (latrepirdine) | Studies (methylene blue) | Trials (methylene blue) | Recent Studies (post-2010) (methylene blue) |
|---|---|---|---|---|---|
| 126 | 7 | 59 | 11,067 | 394 | 4,258 |
| Protein | Taxonomy | latrepirdine (IC50) | methylene blue (IC50) |
|---|---|---|---|
| Chain E, Fibrin beta chain | Homo sapiens (human) | 9.253 | |
| integrase, partial | Human immunodeficiency virus 1 | 1.958 | |
| lens epithelium-derived growth factor p75 | Homo sapiens (human) | 1.958 | |
| Apoptotic peptidase activating factor 1 | Homo sapiens (human) | 15.5 | |
| neutrophil cytosol factor 1 | Homo sapiens (human) | 0.39 | |
| caspase-9 isoform alpha precursor | Homo sapiens (human) | 17 | |
| caspase-3 isoform a preproprotein | Homo sapiens (human) | 17 | |
| Glutathione reductase | Plasmodium falciparum 3D7 | 6.4 | |
| Amyloid-beta precursor protein | Homo sapiens (human) | 0.5 | |
| Microtubule-associated protein tau | Homo sapiens (human) | 2.2333 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.5 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 0.07 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.5 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ge, S; Guan, J; Lin, JP; Liu, XH; Wang, T; Wu, MB; Yang, LR | 1 |
| Gura, T | 1 |
| Akiyama, H; Arai, T; Bachurin, SO; Buchman, VL; Goedert, M; Hasegawa, M; Kametani, F; Ninkina, N; Nonaka, T; Yamashita, M | 1 |
| Gravitz, L | 1 |
1 review(s) available for latrepirdine and methylene blue
| Article | Year |
|---|---|
Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Cholinesterase Inhibitors; Drug Discovery; Humans; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroprotective Agents | 2019 |
4 other study(ies) available for latrepirdine and methylene blue
| Article | Year |
|---|---|
Hope in Alzheimer's fight emerges from unexpected places.
Topics: Alzheimer Disease; Cognition; Humans; Indoles; Methylene Blue; Research | 2008 |
New treatments in the pipeline for Alzheimer's.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Humans; Indoles; Methylene Blue | 2009 |
Methylene blue and dimebon inhibit aggregation of TDP-43 in cellular models.
Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Cell Line; Dementia; DNA-Binding Proteins; Enzyme Inhibitors; Humans; Inclusion Bodies; Indoles; Methylene Blue | 2009 |
Drugs: a tangled web of targets.
Topics: Alanine; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azepines; Clinical Trials as Topic; Disease Progression; Genetic Therapy; Glycogen Synthase Kinase 3; Humans; Indoles; Memantine; Methylene Blue; Molecular Targeted Therapy; Nerve Growth Factor; Neurofibrillary Tangles; Phosphorylation; tau Proteins | 2011 |